Shi R - Search Results

1

Targeting phospholipid remodeling pathway improves insulin resistance in diabetic mouse models.

Tian Y, Lu W, Shi R, McGuffee R, Lee R, Ford DA, Wang B. Tian Y, et al. Among authors: shi r. FASEB J. 2023 Nov;37(11):e23251. doi: 10.1096/fj.202301122RR. FASEB J. 2023. PMID: 37823674

2

Intestinal SEC16B modulates obesity by regulating chylomicron metabolism.

Shi R, Lu W, Tian Y, Wang B. Shi R, et al. Mol Metab. 2023 Apr;70:101693. doi: 10.1016/j.molmet.2023.101693. Epub 2023 Feb 14. Mol Metab. 2023. PMID: 36796587 Free PMC article.

3

Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis.

Tian Y, Jellinek MJ, Mehta K, Seok SM, Kuo SH, Lu W, Shi R, Lee R, Lau GW, Kemper JK, Zhang K, Ford DA, Wang B. Tian Y, et al. Among authors: shi r. Hepatology. 2024 Apr 1;79(4):882-897. doi: 10.1097/HEP.0000000000000375. Epub 2023 Apr 1. Hepatology. 2024. PMID: 36999536

4

Hepatic Phospholipid Remodeling Modulates Insulin Sensitivity and Systemic Metabolism.

Tian Y, Mehta K, Jellinek MJ, Sun H, Lu W, Shi R, Ingram K, Friedline RH, Kim JK, Kemper JK, Ford DA, Zhang K, Wang B. Tian Y, et al. Among authors: shi r. Adv Sci (Weinh). 2023 Jun;10(18):e2300416. doi: 10.1002/advs.202300416. Epub 2023 Apr 23. Adv Sci (Weinh). 2023. PMID: 37088778 Free PMC article.

5

Nutrient metabolism in regulating intestinal stem cell homeostasis.

Shi R, Wang B. Shi R, et al. Cell Prolif. 2024 Feb 22:e13602. doi: 10.1111/cpr.13602. Online ahead of print. Cell Prolif. 2024. PMID: 38386338 Review.

6

AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice.

Nance ME, Shi R, Hakim CH, Wasala NB, Yue Y, Pan X, Zhang T, Robinson CA, Duan SX, Yao G, Yang NN, Chen SJ, Wagner KR, Gersbach CA, Duan D. Nance ME, et al. Among authors: shi r. Mol Ther. 2019 Sep 4;27(9):1568-1585. doi: 10.1016/j.ymthe.2019.06.012. Epub 2019 Jul 3. Mol Ther. 2019. PMID: 31327755 Free PMC article.

7

Effects of weight loss on QTc in people with obesity: a systematic review and meta-analysis.

Li Y, Zhu Y, Jiang X, Tan C, Li K, Shi R, Nie H. Li Y, et al. Among authors: shi r. Acta Cardiol. 2024 May 9:1-16. doi: 10.1080/00015385.2024.2336346. Online ahead of print. Acta Cardiol. 2024. PMID: 38722068 Review.

8

Targeting HSP47 for cancer treatment.

Shi R, Yu R, Lian F, Zheng Y, Feng S, Li C, Zheng X. Shi R, et al. Anticancer Drugs. 2024 Apr 29. doi: 10.1097/CAD.0000000000001612. Online ahead of print. Anticancer Drugs. 2024. PMID: 38718070

9

Comment on "Role of increased plasminogen activator inhibitor-1 and vitronectin in gestational diabetes mellitus".

Yin H, Shi R. Yin H, et al. Among authors: shi r. Rev Assoc Med Bras (1992). 2024 May 3;70(4):e20231607. doi: 10.1590/1806-9282.20231607. eCollection 2024. Rev Assoc Med Bras (1992). 2024. PMID: 38716956 Free PMC article. No abstract available.

10

Emerging strategies for treating autoimmune disease with genetically modified dendritic cells.

Ma Y, Shi R, Li F, Chang H. Ma Y, et al. Among authors: shi r. Cell Commun Signal. 2024 May 7;22(1):262. doi: 10.1186/s12964-024-01641-7. Cell Commun Signal. 2024. PMID: 38715122 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,428 results

Search Page